Search results

Page results

• Professor Bryan Williams elected President of the International Society of Hypertension

  UCLH Director of Research Professor Bryan Williams has been elected as the next President of the International Society of Hypertension (ISH).

• UCLH first in the NHS to use Nanoknife for prostate cancer

  A minimally invasive technique for treating prostate cancer has been used for the first time in the NHS at UCLH. It can be used with precision to treat the affected area, reducing side effects.

• Paediatric patients – advice and support for GPs over Christmas

  We want to make you aware that our children and young people’s teams will be available throughout the holiday period to provide advice and support when needed.

• COVID-19 vaccination effective for most cancer patients but protection wanes more quickly

  COVID-19 vaccines are effective for most cancer patients but the level of protection offered by vaccines against infection, hospitalisation and death is lower compared with the general population and also wanes more quickly, according to a study in which UCLH participated.

• Alternating vaccines trial to include two additional vaccines

  The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.

• Relocation of Hyperacute Stroke Unit

  The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.

• UCLH haematology team wins award

  Charity Myeloma UK awards UCLH haematology team their Clinical Service Excellence Programme (CSEP) award in recognition of their outstanding care and unflagging dedication to patients living myeloma, an incurable blood cancer.

• New patient information

  Information for new neuro-otology patients

• Immunotherapy drug combination stimulates immune system against resistant cancers

  A study at UCLH has found a combination treatment of immunotherapy with an experimental drug may reverse a cancer’s resistance to immunotherapy – making the cancer sensitive to treatment again.

• Research shows immediate reporting of chest X-rays can cut lung cancer diagnosis time in half

  A research study has found that patients who get their chest X-ray results immediately are diagnosed in half the usual time.